Sorry, you need to enable JavaScript to visit this website.

Pfizer is focused on improving treatment options for patients through research and development and manufacturing. Our new state-of-the-art clinical manufacturing facility in Andover, MA expands our capacity to develop and produce more advanced medicines that can improve the lives of patients with chronic autoimmune conditions like rheumatoid arthritis, Crohn’s disease, multiple sclerosis, and even some cancers.

The site will provide 75 new jobs for the Andover area economy, adding to the approximately 2,000 colleagues currently based in Massachusetts. This investment strengthens both the Commonwealth’s economy and Pfizer’s efforts to improve patient access to potentially life-changing treatments.

Similarly, our Ready for Cures initiative is dedicated to improving access to life-saving medicines and fostering a public policy environment that supports healthcare innovation. We believe policy challenges across the healthcare system are stifling the full potential of today’s scientific breakthroughs.

We need your support to show elected officials that it’s time to invest in research and innovation and remove barriers that continue to stand between life-saving medications and the patients who need them the most.